Drugs / LV
last change Apr 2024 re-read 2 minutes ago

LV

Developed for
pancreatic exocrine neoplasm
Investigated by
Du Juan

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT06494514 Apr 2024 → Apr 2027 expected pancreatic exocrine neoplasm Du Juan Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LV ClinicalTrials.gov intervention name — accepted as the source's own label NCT06494514